Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • India rejects 955...

    India rejects 955 pharma patent applications in last three years

    Written by savita thakur thakur Published On 2016-07-26T13:07:34+05:30  |  Updated On 26 July 2016 1:07 PM IST
    India rejects 955 pharma patent applications in last three years

    New Delhi : India has rejected as many as 955 patent applications in the pharmaceutical sector in the last three years.


    "618 applications have been rejected citing Section 3 (d) of the Patents Act, 1970, as one of the grounds for rejection in the last three years," Commerce and Industry Minister Nirmala Sitharaman said in a written reply to the Lok Sabha.


    "A total of 955 patent applications in pharma have been rejected by the Indian Patent Office (IPO) in the last three years."


    To a separate query, she said India is considered as a leading exporter and holds second position in export of generic drugs in terms of volumes.


    Replying separately, the minister said there was a slowdown in exports from SEZs because of reasons like withdrawal of exemptions of minimum alternate tax and dividend distribution tax and uncertain fiscal regime for SEZs and global factors.


    In 2015-16, exports from these zones grew only 0.77 per cent to Rs 4.67 lakh crore.


    So far, 29 cases have been reported as fraud in the SEZs in the country on which appropriate action has been initiated or taken by the concerned authorities, Sitharaman said. The companies include Rajesh Exports, Tata International and Sun Solution.


    There are 204 functional SEZs so far in the country and 226 non-functional.

    955 patent applicationsIndian Patent OfficeIPONirmala SitharamanpatentPatents ActSEZs
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok